Thu, Nov 05, 2026 - Page 12
18132 indexed SquawkNews stories from this UTC day. Showing 1321-1440.
M
Castle Biosciences Reports Q3 Revenue of $102.9 Million, Raises 2026 Guidance
Q3 2026 revenue rose 24% year over year, while TissueCypher test report volume increased 47%. Castle Biosciences raised full-year 2026 revenue guidance to $385–395 million, from a prior range.
EQUITY | Nov 05, 2026, 09:06 PM UTC
L
Lam Research Authorizes Up to $25B in Share Repurchases
Lam Research authorized up to $25 billion in share repurchases and declared a quarterly dividend of $0.33. The dividend is payable Jan. 6, 2027, to holders of record Dec. 2, 2026.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Puma Biotechnology Q3 Net Income Falls to $6.0M
Q3 2026 revenue was $55.1 million, up from $54.5 million a year earlier; GAAP net income fell to $6.0 million from $8.8 million.
EARNINGS | Nov 05, 2026, 09:06 PM UTC
M
Sarepta Q3 Revenue Falls 4.5% to $381.4 Million Year Over Year
Third-quarter 2026 revenue was $381.4 million, down from $399.4 million in the same period of 2025, primarily due to lower ELEVIDYS sales following its updated label. The company cited upcoming DM1 and FSHD datasets as o
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Artivion Reports Third-Quarter 2026 Financial Results
Artivion announced financial results for the quarter ended September 30, 2026.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Cryoport Raises 2026 Revenue Guidance to $197M–$199M
Cryoport reported Q3 2026 revenue of $50.2 million and adjusted EBITDA from continuing operations of $1.1 million. Commercial CGT revenue rose 20% year over year; the company did not provide its prior guidance range.
EARNINGS | Nov 05, 2026, 09:06 PM UTC
M
Lyft Reports Q3 2026 Results, TTM Cash Generation Tops $1B
Lyft said trailing 12-month cash generation exceeded $1.0 billion for the fifth straight quarter. The release provides no Q3 financial figures or Q4 outlook values.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Workiva Announces Third-Quarter 2026 Financial Results
Workiva reported results for the quarter ended September 30, 2026; the supplied excerpt provides no financial figures.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Diodes Q3 Revenue Rises 35.8% to $532.6M; Issues Q4 Outlook
Preliminary, unaudited Q3 2026 revenue rose 19.5% sequentially to $532.6M. GAAP diluted EPS was $0.95, versus $0.31 a year earlier. The company expects Q4 revenue of approximately $550M, plus or minus 3%, and adjusted EP
EQUITY | Nov 05, 2026, 09:06 PM UTC
L
BJ's Restaurants Reports Third-Quarter Net Income of $5.32 Million
EARNINGS | Nov 05, 2026, 09:06 PM UTC
M
Teradata Reports Third-Quarter 2026 Financial Results
Teradata announced its third-quarter 2026 financial results; the supplied text contains no reported figures.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
FIGS Raises Full-Year Revenue and Adjusted EBITDA Margin Outlook
FIGS reported Q3 net revenue growth of 26% and an adjusted EBITDA margin of 16.5%, up 410 basis points. It raised its full-year net revenue and adjusted EBITDA margin outlooks.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
PRA Group Reports Third-Quarter 2026 Results
PRA Group reported $15 million of net income attributable to the company for the quarter.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Lyft Reports Strong Q3 2026 Results
Lyft reported results for the quarter ended September 30, 2026, and announced the launch of Lyft Go.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
JFrog Announces Third-Quarter 2026 Results
JFrog announced results for the quarter ended September 30, 2026.
EQUITY | Nov 05, 2026, 09:06 PM UTC
L
Vaxart 3Q Loss/Shr 4c >VXRT
Vaxart 3Q Loss/Shr 4c >VXRT
EQUITY | Nov 05, 2026, 09:06 PM UTC
L
Vaxart 3Q Rev $72.4M >VXRT
Vaxart 3Q Rev $72.4M >VXRT
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
10x Genomics Reports Third-Quarter 2026 Financial Results
10x Genomics reported results for the quarter ended September 30, 2026.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Sunrise Realty Trust and Southern Realty Trust Complete Merger
Sunrise Realty Trust and Southern Realty Trust announced completion of their merger.
MNA | Nov 05, 2026, 09:06 PM UTC
L
MNTN to Participate in Upcoming Investor Conferences
MNTN (NYSE:MNTN), a technology platform that brings performance marketing to Connected TV, announced today, that CEO Tony Weisman will host one-on-one investor meetings along with CFO Patrick Pohlen at the following inve
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Solventum Reports Third-Quarter Sales of $1.9 Billion
Solventum reported sales of $1.9 billion for the third quarter.
EARNINGS | Nov 05, 2026, 09:06 PM UTC
L
Natera 3Q Rev $794M >NTRA
Natera 3Q Rev $794M >NTRA
EQUITY | Nov 05, 2026, 09:06 PM UTC
L
Natera 3Q Loss/Shr 42c >NTRA
Natera 3Q Loss/Shr 42c >NTRA
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Surf Air Mobility Reports Third-Quarter 2026 Results, Meets Guidance
Surf Air Mobility reported results for the quarter ended September 30, 2026, and said it met revenue and adjusted EBITDA guidance.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
Globant to Report Third-Quarter 2026 Results on November
Globant said it will release results for the quarter ended September, 2026, after market close on November, 2026.
EQUITY | Nov 05, 2026, 09:06 PM UTC
L
Globus Medical 3Q Sales $763.7M >GMED
Globus Medical 3Q Sales $763.7M >GMED
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
Diodes Reports Third-Quarter 2026 Financial Results
Diodes reported results for the quarter ended September 30, 2026. The company said revenue reached record levels and referred to an increase of over 500, but the body is truncated before the metric is identified.
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
Puma Biotechnology Reports Third-Quarter 2026 Financial Results
Puma Biotechnology announced results for the quarter ended September 30, 2026. The supplied report excerpt contains no financial figures.
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
Cryoport Reports Third-Quarter 2026 Financial Results
Cryoport announced results for the third quarter and first nine months of 2026.
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
Farmer Mac Reports Third-Quarter 2026 Results
Farmer Mac reported results for the quarter ended September 30, 2026, and cited outstanding business volume of $38.5 billion.
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
BRIXMOR PROPERTY GROUP CLOSES $400 MILLION UNSECURED TERM LOAN
NEW YORK, Nov. 5, 2026 // -- Brixmor Property Group Inc. (NYSE:BRX) ("Brixmor" or the "Company") announced today that its operating partnership, Brixmor Operating Partnership LP (the "Operating Partnership"), has closed
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
Halozyme Therapeutics 3Q Rev $493M >HALO
Halozyme Therapeutics 3Q Rev $493M >HALO
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
MP Materials Rare Earth Earnings Were Rock Solid. What's Up With the Stock? — Barrons.com
By Al RootMP Materials investors might get some relief from the company's third-quarter results after a wave of selling battered the rare earth miner's shares.MP on Thursday reported better-than-expected quarterly figure
EARNINGS | Nov 05, 2026, 09:05 PM UTC
M
AEye Reports Third-Quarter 2026 Results; Revenue Rises About 10x Year Over Year
AEye said revenue increased approximately 10x year over year and 2.5x sequentially for the quarter ended September 30, 2026.
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
Quest Resource Holding 3Q Rev $63.8M >QRHC
Quest Resource Holding 3Q Rev $63.8M >QRHC
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
Halozyme Therapeutics 3Q Net $247M >HALO
Halozyme Therapeutics 3Q Net $247M >HALO
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
Halozyme Therapeutics 3Q EPS $2.01 >HALO
Halozyme Therapeutics 3Q EPS $2.01 >HALO
EARNINGS | Nov 05, 2026, 09:05 PM UTC
M
Sarepta Therapeutics Reports Third-Quarter 2026 Financial Results
Sarepta reported its third-quarter 2026 financial results. The supplied body is truncated and provides no figures.
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
Fox Factory Holding 3Q Loss/Shr $2.61 >FOXF
Fox Factory Holding 3Q Loss/Shr $2.61 >FOXF
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
Fox Factory Holding 3Q Adj EPS 54c >FOXF
Fox Factory Holding 3Q Adj EPS 54c >FOXF
EARNINGS | Nov 05, 2026, 09:05 PM UTC
L
Blink Charging Reports Q3 EPS of -$0.05
Reuters reports Blink Charging's Q3 EPS was USD -0.05.
EARNINGS | Nov 05, 2026, 09:05 PM UTC
M
Celldex Reports Q3 2026 Net Loss of $75.6 Million
Celldex reported a third-quarter 2026 net loss of $75.6 million, or $0.96 per share, versus a $67.0 million loss a year earlier. Revenue was zero and research and development expenses were $67.4 million.
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
Omada Health Q3 Revenue Rises 34% to $91.3 Million, Raises 2026 Outlook
Omada Health reported Q3 2026 net income of $6.6 million, versus a loss a year earlier. Gross margin was 76% and Adjusted EBITDA was $12.4 million.
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
FIGS Releases Third Quarter 2026 Financial Results
FIGS, Inc. (NYSE:FIGS) (the “Company”), the leading global healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its third quarter 2026 financial results and published a fi
EARNINGS | Nov 05, 2026, 09:05 PM UTC
M
Mattel Reports Third-Quarter 2026 Financial Results
Mattel reported third-quarter 2026 financial results. CEO Roger Lynch said the company will focus resources on its greatest priorities.
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
Trupanion Q3 Revenue Rises 11% to $405.6 Million
Trupanion reported third-quarter 2026 net income of $9.3 million, operating income of $9.5 million, adjusted EBITDA of $20.8 million and operating cash flow of $30.7 million.
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
Keros Therapeutics Reports $14.2 Million Third-Quarter Net Income
Keros Therapeutics reported third-quarter 2026 revenue of $40.0 million and net income of $14.2 million, versus revenue of $14.3 million and a net loss of $7.3 million a year earlier. The company said its cash and cash e
EARNINGS | Nov 05, 2026, 09:05 PM UTC
L
Renatus Tactical Acquisition Says Devin Nunes Resigned as Chairman and Director
The company said Nunes’s resignation was effective October 31, 2026.
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
BILL Reports Q1 FY2027 Revenue of $353.8M, Core Revenue Up 14.3%
BILL reported Q1 FY2027 total revenue of $353.8 million and core revenue of $316.4 million, up 14.3% year over year. Non-GAAP operating income was $136.9 million and diluted EPS was $1.18. The company also issued Q2 and
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
Acumen Repays K2 HealthVentures Loan for Approximately $23.3 Million
Acumen repaid approximately $23.3 million to K2 HealthVentures on November 5, 2026, terminating its November 2023 loan agreement ahead of its scheduled November 2027 maturity. The payoff included outstanding principal, a
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
BlackLine Sees Fourth-Quarter Adjusted EPS
EARNINGS | Nov 05, 2026, 09:05 PM UTC
L
PRA Group 3Q Rev $286.3M >PRAA
PRA Group 3Q Rev $286.3M >PRAA
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
Tandem Diabetes Care 3Q Loss/Shr 10c >TNDM
Tandem Diabetes Care 3Q Loss/Shr 10c >TNDM
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
Janux Therapeutics Reports Third-Quarter 2026 Financial Results
Janux reported financial results for the quarter ended September 30, 2026, and provided a business update.
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
BlackLine Sees FY Adjusted EPS of $2.48–$2.49
EARNINGS | Nov 05, 2026, 09:05 PM UTC
L
El Pollo Loco Holdings 3Q Net $6.88M >LOCO
El Pollo Loco Holdings 3Q Net $6.88M >LOCO
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
BlackLine 3Q Rev $193.4M >BL
BlackLine 3Q Rev $193.4M >BL
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
BlackLine Sees FY Revenue at $759.5M–$761.5M
EARNINGS | Nov 05, 2026, 09:05 PM UTC
L
BlackLine 3Q Net $10.6M >BL
BlackLine 3Q Net $10.6M >BL
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
BridgeBio Oncology Therapeutics' Yong Ben to Resign as Chief Medical and Development Officer
BridgeBio Oncology Therapeutics said Yong Ben will resign as chief medical and development officer, effective January 8, 2027.Original SEC Filing: BridgeBio Oncology Therapeutics, Inc. [ BBOT ] - 8-K - Nov. 05, 2026This
REGULATION | Nov 05, 2026, 09:05 PM UTC
L
BlackLine 3Q Adj EPS 64c >BL
BlackLine 3Q Adj EPS 64c >BL
EARNINGS | Nov 05, 2026, 09:05 PM UTC
M
TransMedics reports Q3 EPS of $0.46, revenue of $203 million
TransMedics Group reported Q3 revenue of $203 million versus the IBES estimate of $177.6 million.
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
BlackLine Sees 4Q Rev $195M-$197M >BL
BlackLine Sees 4Q Rev $195M-$197M >BL
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
BlackLine 3Q EPS 18c >BL
BlackLine 3Q EPS 18c >BL
EARNINGS | Nov 05, 2026, 09:05 PM UTC
L
IonQ’s Latest Results Support Its Quantum Computing Ambitions
IonQ reported its latest earnings, and leadership expects commercial momentum to build. The available report excerpt gives no financial figures.
EARNINGS | Nov 05, 2026, 09:05 PM UTC
L
ICF International 3Q Net $31.7M >ICFI
ICF International 3Q Net $31.7M >ICFI
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
ICF International 3Q Rev $470.5M >ICFI
ICF International 3Q Rev $470.5M >ICFI
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
ICF International 3Q EPS $1.76 >ICFI
ICF International 3Q EPS $1.76 >ICFI
EARNINGS | Nov 05, 2026, 09:05 PM UTC
L
Lyft CFO Sees Strength Across All Geographies in 3Q, With Acceleration in North America
Lyft CFO Sees Strength Across All Geographies in 3Q, With Acceleration in North America
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
Solventum Sees FY Adjusted EPS of $7.20–$7.30
EARNINGS | Nov 05, 2026, 09:05 PM UTC
L
Lyft Partnerships, New Products Driving Demand in North America, CFO Brous Says
Lyft Partnerships, New Products Driving Demand in North America, CFO Brous Says
EQUITY | Nov 05, 2026, 09:05 PM UTC
L
Canada trims budget deficit forecasts for every year until 2030/31
OTTAWA, Nov 5 (Reuters) - The Canadian government on Thursday trimmed its budget deficit forecasts for every fiscal year until 2030/31 and said 2027 growth would be slightly less than initially expected.* Ottawa said the
GEOPOLITICS | Nov 05, 2026, 09:05 PM UTC
M
Celcuity Reports Q3 Adjusted EPS of USD -1.21
Celcuity reported Q3 net income of USD -73.3 million.
EARNINGS | Nov 05, 2026, 09:05 PM UTC
L
Canada says it plans to increase total borrowing in 2027/28
OTTAWA, Nov 5 (Reuters) - Canada plans to increase its total borrowing in 2027/28 to C$611 billion from C$587 billion in 2026/27, the finance ministry said in the annual budget on Thursday. (Reporting by David Ljunggren,
EQUITY | Nov 05, 2026, 09:05 PM UTC
M
Consensus Cloud Solutions Reports Q3 2026 Results, Updates Guidance
Consensus Cloud Solutions reported third-quarter 2026 results, issued Q4 guidance, narrowed its full-year 2026 revenue and adjusted EBITDA guidance, and raised its adjusted earnings-per-diluted-share guidance.
EQUITY | Nov 05, 2026, 09:04 PM UTC
M
Premium Brands Holdings Reports Q3 Adjusted EBITDA of CAD 213 Million
Reuters reports Q3 revenue of CAD 19 million versus an IBES estimate of CAD 2,395 million.
EARNINGS | Nov 05, 2026, 09:04 PM UTC
L
BRIEF-Verastem Q3 Operating Expenses USD 99.236 Million
Nov 05 (Reuters) - Verastem Q3 net income USD -74.723 million.
EARNINGS | Nov 05, 2026, 09:04 PM UTC
M
Axon Announces $1.2B Investment in Skydio
Axon Enterprise announced a $1.2 billion investment in Skydio.
MNA | Nov 05, 2026, 09:04 PM UTC
L
BoC Framework Reaffirms Price Stability As Main Goal; Bank And Finance Ministry To Release Renewal Today
BoC Framework Reaffirms Price Stability As Main Goal; Bank And Finance Ministry To Release Renewal Today
NEWS | Nov 05, 2026, 09:04 PM UTC
L
BRIEF-Voyager Therapeutics Q3 Operating Income USD -26.422 Million
Nov 05 (Reuters) - Voyager Therapeutics Q3 net income USD -24.694 million.
EARNINGS | Nov 05, 2026, 09:04 PM UTC
L
Canada Budget Includes C$151.5B In New Spending Over Five Years
C$45B For Housing; C$25B To Seed New Canada Growth Fund - Tax Breaks For Successful Startups - Debt-To-GDP Ratio Expected To Rise To 40.1% In 2030 31 - Deficit-To-GDP Ratio To Fall From 1.8% To 1.3% By 2031 - Treasury Bi
MACRO | Nov 05, 2026, 09:04 PM UTC
L
BRIEF-Howard Hughes Q3 Net Income USD -1.1 Million
Nov 05 (Reuters) - Howard Hughes Q3 NOI USD 73 million.
EARNINGS | Nov 05, 2026, 09:04 PM UTC
L
BRIEF-Arcturus Therapeutics Q3 Net Income USD -7.414 Million
Nov 05 (Reuters) - Arcturus Therapeutics Q3 basic EPS USD -0.26.
EARNINGS | Nov 05, 2026, 09:04 PM UTC
M
Doximity Q2 Revenue Reaches USD 174.537 Million
Doximity reported Q2 net income of USD 34.73 million. Revenue was above the supplied IBES estimate of USD 170.8 million.
EQUITY | Nov 05, 2026, 09:04 PM UTC
M
Bill Reports Q1 Revenue of $353.8 Million, Below IBES Estimate
Bill reported Q1 adjusted net income of $119.1 million, above the IBES estimate of $98.5 million.
EQUITY | Nov 05, 2026, 09:04 PM UTC
M
Perdoceo Education Reports Third-Quarter and Year-to-Date 2026 Results
Perdoceo Education reported operating and financial results for the third quarter and year to date ended September 30, 2026. The company said third-quarter operating performance was ahead of its expectations.
EQUITY | Nov 05, 2026, 09:04 PM UTC
M
Dropbox Announces Third-Quarter 2026 Results
Dropbox said revenue growth excluding FormSwift and non-GAAP operating margin were ahead of its guidance. The company described the quarter as its fifth consecutive quarter of year-over-year growth.
EQUITY | Nov 05, 2026, 09:04 PM UTC
L
BRIEF-Turtle Beach Q3 Revenue USD 84.7 Million Vs. IBES Estimate USD 93.8 Million
Nov 05 (Reuters) - Turtle Beach Q3 gross margin 34.9%.
EARNINGS | Nov 05, 2026, 09:04 PM UTC
L
MannKind Q3 Basic EPS Is -$0.07
MannKind reported Q3 pretax profit of USD -23.173 million.
EARNINGS | Nov 05, 2026, 09:04 PM UTC
L
NMI Holdings Q3 Adjusted EPS USD 1.23 vs. IBES Estimate USD 1.3
Reuters reports Q3 EPS of USD 1.23; adjusted EPS was USD 1.23 versus an IBES estimate of USD 1.3.
EARNINGS | Nov 05, 2026, 09:04 PM UTC
M
Biodesix Q3 Revenue Was USD 24.041 Million, Below IBES Estimate
Biodesix reported Q3 operating expenses of USD 30.153 million.
EQUITY | Nov 05, 2026, 09:04 PM UTC
M
PDF Solutions Q3 Adjusted EPS USD 0.40 vs. IBES Estimate USD 0.33
PDF Solutions reported Q3 net income of USD 6.841 million.
EARNINGS | Nov 05, 2026, 09:04 PM UTC
L
Akamai Technologies Reports Third-Quarter Adjusted EPS of $1.77
EARNINGS | Nov 05, 2026, 09:04 PM UTC
L
BRIEF-Cogent Biosciences Q3 Income From Operations USD -117.184 Million
Nov 05 (Reuters) - Cogent Biosciences Q3 operating expenses USD 117.184 million.
FX | Nov 05, 2026, 09:04 PM UTC
L
Dropbox 3Q Paying Users 18.2M >DBX
Dropbox 3Q Paying Users 18.2M >DBX
EQUITY | Nov 05, 2026, 09:04 PM UTC
L
Dropbox 3Q Net $116.1M >DBX
Dropbox 3Q Net $116.1M >DBX
EQUITY | Nov 05, 2026, 09:04 PM UTC
L
Dropbox 3Q Rev $637.3M >DBX
Dropbox 3Q Rev $637.3M >DBX
EQUITY | Nov 05, 2026, 09:04 PM UTC
L
Dropbox 3Q EPS 52c >DBX
Dropbox 3Q EPS 52c >DBX
EARNINGS | Nov 05, 2026, 09:04 PM UTC
L
Dropbox 3Q Adj EPS 88c >DBX
Dropbox 3Q Adj EPS 88c >DBX
EARNINGS | Nov 05, 2026, 09:04 PM UTC
L
Canada Unveils 2026 Budget With C$45 Billion Housing Plan, Higher Borrowing and Slower Growth Outlook
Canada's 2026 budget includes C$45 billion in housing affordability measures and C$25 billion to establish a new Canada Growth Fund Canada forecasts 2026 GDP growth of 1.0%, down from 1.1% previously, and 2027 growth of
MACRO | Nov 05, 2026, 09:04 PM UTC
L
S&P 500 Unofficially Closes Down 4.33% At 7,355.81, Losing 332.81 Points
S&P 500 Unofficially Closes Down 4.33% At 7,355.81, Losing 332.81 Points
NEWS | Nov 05, 2026, 09:04 PM UTC
L
BRIEF-Trisura Group Ltd. Q3 ROE 16.2%
Nov 05 (Reuters) - Trisura Group Ltd. Q3 EPS CAD 0.54.
EARNINGS | Nov 05, 2026, 09:04 PM UTC
M
Accendra Health Q3 Revenue $601.8 Million, Adjusted EBITDA $47.8 Million
Q3 revenue was $601.8 million versus an IBES estimate of $617.4 million; adjusted EBITDA was $47.8 million versus an estimate of $74.1 million.
EQUITY | Nov 05, 2026, 09:04 PM UTC
L
Axon Enterprise Says AI Bookings Are Up Over 50% Year to Date
EQUITY | Nov 05, 2026, 09:04 PM UTC
L
Blink Charging Files 8K - Other Events >BLNK
Blink Charging Co. (BLNK) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on November 05, 2026.On November 3, 2026, the Board of Directors (the "Board") of the Company appointed Michael B
EQUITY | Nov 05, 2026, 09:04 PM UTC
L
BRIEF-Neighborhood Intelligence Inc Q3 Operating Income USD -62.069 Million Vs. IBES Estimate USD -44.2 Million
Nov 05 (Reuters) - Neighborhood Intelligence Inc Q3 gross profit USD 172.945 million.
EARNINGS | Nov 05, 2026, 09:03 PM UTC
L
BRIEF-Vera Therapeutics Q3 Net Income USD -93.711 Million Vs. IBES Estimate USD -117.1 Million
Nov 05 (Reuters) - Vera Therapeutics Q3 operating income USD -95.702 million vs. IBES estimate USD -119 million.
EARNINGS | Nov 05, 2026, 09:03 PM UTC
L
Blink Charging Files 8K - Operations And Financial Condition >BLNK
Blink Charging Co. (BLNK) filed a Form 8K - Operations and Financial Condition - with the U.S Securities and Exchange Commission on November 05, 2026.Blink Charging Co. NASDAQ:BLNK (the "Company"), a leading owner and op
EQUITY | Nov 05, 2026, 09:03 PM UTC
M
Corsair Gaming Raises FY26 Adjusted EPS View to 89c–94c
Corsair Gaming raised its FY26 adjusted EPS view to 89c–94c.
EARNINGS | Nov 05, 2026, 09:03 PM UTC
L
Corsair Gaming Raisies Full-Yr Outlook >CRSR
Corsair Gaming Raisies Full-Yr Outlook >CRSR
EQUITY | Nov 05, 2026, 09:03 PM UTC
L
Smart Sand Files 8K - Other Events >SND
Smart Sand Inc. (SND) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on November 05, 2026.On November 5, 2026, the Board of Directors of the Company declared a special dividend of $0.05
EQUITY | Nov 05, 2026, 09:03 PM UTC
M
Wynn Q3 Adjusted EPS $0.33 vs. IBES Estimate $0.68
Reuters reports Q3 EPS of $0.17.
EARNINGS | Nov 05, 2026, 09:03 PM UTC
M
Apple reportedly set to raise $7.5 billion in bond offering
Bloomberg reported the offering drew roughly $31 billion in orders, more than four times the deal’s ultimate size.
EQUITY | Nov 05, 2026, 09:03 PM UTC
M
TransMedics Reports Third-Quarter 2026 Results, Raises Full-Year Guidance
TransMedics said strong revenue generation drove an increase in its full-year 2026 guidance.
EQUITY | Nov 05, 2026, 09:03 PM UTC
M
Airbnb Announces Third-Quarter 2026 Results
Airbnb posted a shareholder letter containing its third-quarter 2026 financial results on its investor relations website.
EQUITY | Nov 05, 2026, 09:03 PM UTC
M
Kratos Sees Fourth-Quarter Revenue at $480M-$510M
EARNINGS | Nov 05, 2026, 09:03 PM UTC
L
Corvus Pharmaceuticals 3Q Loss/Shr 22c >CRVS
Corvus Pharmaceuticals 3Q Loss/Shr 22c >CRVS
EQUITY | Nov 05, 2026, 09:03 PM UTC
M
Kratos Sees FY26 Revenue of $1.78B-$1.81B
EARNINGS | Nov 05, 2026, 09:03 PM UTC
L
Longeveron director Ursula Ungaro resigns from board and committees
Longeveron director Ursula Ungaro resigned immediately from the board and four committees, citing personal health issues.Original SEC Filing: Longeveron Inc. [ LGVN ] - 8-K - Nov. 05, 2026This is an AI-powered summary. I
REGULATION | Nov 05, 2026, 09:03 PM UTC
M
Canada's $100B Budget Plan Fueled by Oil Windfall
By Paul VieiraOTTAWA--Higher energy prices and better-than-expected economic strength has improved Canada's fiscal profile, according to the Liberal government's annual budget plan, giving Prime Minister Mark Carney addi
ENERGY | Nov 05, 2026, 09:03 PM UTC